قارن الطرق
راجع الطرق التي اخترتها جنبًا إلى جنب؛ الصفوف المختلفة مميَّزة.
| تحليل فعالية التكلفة في تقييم التكنولوجيا الصحية× | تقييم تكنولوجيا الرعاية الصحية× | |
|---|---|---|
| المجال | إدارة الرعاية الصحية | إدارة الرعاية الصحية |
| العائلة | Process / pipeline | Process / pipeline |
| سنة النشأة≠ | 1996 | 1980 |
| صاحب الطريقة≠ | Diane Meade Drummond, Michael Gold | International HTA organizations, National Institutes of Health |
| النوع≠ | Economic evaluation methodology | Structured assessment methodology |
| المصدر التأسيسي≠ | Gold, M. R., Siegel, J. E., Russell, L. B., & Weinstein, M. C. (Eds.). (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press. ISBN: 9780195108231 | Goodman, C. S. (2004). HTA 101: Introduction to Health Technology Assessment (Version 1.0). National Library of Medicine, National Institutes of Health. link ↗ |
| الأسماء البديلة | CEA, Cost-Effectiveness Analysis Healthcare | HTA, Technology Assessment Healthcare |
| ذات صلة | 5 | 5 |
| الملخص≠ | Cost-Effectiveness Analysis (CEA) is an economic evaluation method that compares the cost and health benefits of alternative treatments to determine whether an intervention provides good value for money. Within Health Technology Assessment, CEA is the primary tool for recommending reimbursement and coverage decisions. | Health Technology Assessment (HTA) is a structured, multidisciplinary approach to evaluating the clinical, economic, and societal effects of healthcare technologies (devices, drugs, procedures, systems). HTA synthesizes evidence from clinical trials, observational studies, and economic analyses to support decision-makers in adoption and reimbursement determinations. |
| ScholarGateمجموعة البيانات ↗ |
|
|